TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 56 filers reported holding TOKAI PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $343,000 | -2.3% | 411,100 | +14.4% | 0.00% | -100.0% |
| Q4 2016 | $351,000 | +6.4% | 359,200 | +66.3% | 0.00% | 0.0% |
| Q3 2016 | $330,000 | +334.2% | 216,000 | +1465.2% | 0.00% | – |
| Q2 2016 | $76,000 | -20.8% | 13,800 | -19.8% | 0.00% | – |
| Q1 2016 | $96,000 | -73.9% | 17,200 | -59.2% | 0.00% | -100.0% |
| Q4 2015 | $368,000 | – | 42,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Owl Capital Management, LLC | 132,500 | $1,155,000 | 1.36% |
| Novo Holdings A/S | 470,946 | $4,107,000 | 0.40% |
| Opus Point Partners Management, LLC | 62,007 | $541,000 | 0.36% |
| Perceptive Advisors | 485,338 | $4,232,000 | 0.31% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $305,000 | 0.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 87,983 | $767,000 | 0.04% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $52,000 | 0.02% |
| Alyeska Investment Group, L.P. | 251,797 | $2,196,000 | 0.02% |
| A.R.T. Advisors, LLC | 27,490 | $239,000 | 0.01% |
| ALPS ADVISORS INC | 29,753 | $259,000 | 0.00% |